Word: bone
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...party. "David took a much stronger line than I did in [the leadership contest]," says David Davis. "He would use a word like detoxifying the party. He thought that was the predominant mission, and arguably he was right." That meant Cameron ditching some of his own bred-in-the-bone leanings toward social conservatism. In 2003 Cameron opposed the repeal of 1988 legislation banning local authorities and schools from "promoting" homosexuality. He now says his earlier stance was a mistake...
...industrial feedlots, which bleed antibiotics and other noxious chemicals. And of course, the human health impact of too much meat can be seen in everything from bloated waistlines in America to rising rates of cardiovascular disease in developing nations, where heart attacks were once as rare as a T-bone steak...
...principle ought to be bred in the bone of any European after the carnage of the 20th century: that no act of state bears such ominous consequences as changing a border by force. Plenty of passionate voices said as much after Russian troops rolled into Georgia's breakaway province of South Ossetia on Aug. 8. On the night of Aug. 12, a day when Russian planes dropped cluster bombs on the town of Gori, the Presidents of Estonia, Latvia, Lithuania, Poland and Ukraine took the stage in front of the Georgian parliament building beside Georgian President Mikheil Saakashvili. "Everyone...
Some of the latest weapons in Big Pharma's arsenal result from that understanding. Gleevec, for instance, treats one form of leukemia by zeroing in on the Philadelphia (Ph) chromosome, that part of the genome that directs bone marrow to keep making abnormal white blood cells. Because of drugs like Gleevec and therapies such as bone-marrow and stem-cell transplants, there are 12 million people walking around today who are classified as survivors...
...Silicon Valley than Big Pharma to support research that in four years got four new treatments to patients--Thalomid, Velcade, Revlimid and Doxil. That's about six years faster than the decade it usually takes for such drug development and rollout. Multiple myeloma is a rare cancer of the bone marrow that sickens about 20,000 Americans each year--precisely the uncommon form of the disease that often falls into the research cracks. The MMRF benefited from the aggressive work of founder Kathy Giusti, a multiple-myeloma survivor and former pharmaceutical executive. When she and her group first raised enough...